Wright Melissa A, Abboud Joseph A, Murthi Anand M
Department of Orthopaedic Surgery, MedStar Union Memorial Hospital, 3333 North Calvert Street, Suite 400, Baltimore, MD, 21218, USA.
Rothman Institute/Thomas Jefferson Medical Center, Philadelphia, PA, USA.
Curr Rev Musculoskelet Med. 2020 Oct;13(5):584-591. doi: 10.1007/s12178-020-09661-9.
Massive irreparable rotator cuff tears present a treatment challenge for the orthopedic surgeon. There is no gold standard among numerous treatment options including nonoperative management, partial repair, debridement, superior capsular reconstruction, and reverse shoulder arthroplasty. In recent years, yet another option, an implantable biodegradable subacromial balloon spacer has become available with promising early results.
Biomechanical studies have demonstrated that the balloon spacer effectively restores the normal humeral head position and glenohumeral joint mechanics. This device has been used in Europe since 2012 with promising clinical results. Most of the studies on this implantable balloon represent single surgeon uncontrolled case series with small numbers of patients, but they report improvements in pain and function following spacer placement, with the longest term studies reporting maintenance of improvements for up to 5 years. Certain studies have shown a benefit when the procedure is done in isolation as well as in combination with other arthroscopic procedures, such as partial rotator cuff repair. The balloon subacromial spacer is a promising new device that can be used in the treatment of patients with massive, irreparable rotator cuff tears. In our experience, patients without arthritis who have active forward elevation over 90 degrees and an intact subscapularis have the best chance of a good outcome. We recommend performing the procedure arthroscopically along with any other indicated procedures including debridement, partial repair, and biceps tenotomy or tenodesis. High-quality long-term studies are needed to better define the indications and outcomes of the implantable balloon spacer in the management of irreparable cuff tears.
巨大不可修复的肩袖撕裂给骨科医生带来了治疗挑战。在众多治疗选择中,包括非手术治疗、部分修复、清创、上盂唇重建和反式肩关节置换术,尚无金标准。近年来,另一种选择,即可植入的可生物降解肩峰下球囊间隔器已面市,早期结果令人鼓舞。
生物力学研究表明,球囊间隔器可有效恢复肱骨头的正常位置和盂肱关节力学。自2012年以来,该装置已在欧洲使用,临床结果令人鼓舞。大多数关于这种可植入球囊的研究为单术者非对照病例系列,患者数量较少,但报告称放置间隔器后疼痛和功能有所改善,长期研究报告称改善情况可持续长达5年。某些研究表明,该手术单独进行以及与其他关节镜手术(如部分肩袖修复)联合进行时均有益处。肩峰下球囊间隔器是一种有前景的新装置,可用于治疗巨大不可修复的肩袖撕裂患者。根据我们的经验,无关节炎、主动前举超过90度且肩胛下肌完整的患者获得良好结果的机会最大。我们建议在关节镜下进行该手术,同时进行任何其他必要的手术,包括清创、部分修复以及肱二头肌切断术或固定术。需要高质量的长期研究来更好地确定可植入球囊间隔器在治疗不可修复肩袖撕裂中的适应症和结果。